MedTech Global Tooling Expansion

MedTech Global Tooling Expansion

The MedTech Group Inc., South Plainfield, NJ today announced plans for expansion of their global capabilities. The company will be establishing a best-in-class mold building presence in Heredia, Costa Rica. MedTech is an FDA registered, ISO 13485:2003 certified Medical Device Manufacturer which began operations in Costa Rica in 2004. In 2009, MedTech opened its second Costa Rican facility to manufacture complete medical devices. Their Costa Rica manufacturing facilities, which total 60,000 square feet, enable the company to provide low-cost cleanroom injection molding, product assembly and packaging services to the medical device industry in a best-in-class environment. The Costa Rica mold building operation will provide the latest in mold building technology to support their customers' strict requirements for superior quality molds.  The company will be focusing its New Jersey mold building resources on providing outstanding tooling design and engineering as well as keeping on the cutting edge of injection molding and mold building technology.

The MedTech Group President and CEO, George W. Blank, noted that, "We have had a very positive experience thus far in Costa Rica, and have found the skill level, dedication and craftsmanship of our employees to be exceptional. As we seek to provide enhanced value and speed to market for all of our customers it seemed only natural to expand operations in Costa Rica to include a full compliment of tool building capabilities. We are also excited at being able to provide this service to all of our customers in Costa Rica".  

Since 1979, The MedTech Group has been providing high quality, precision injection molded parts to the medical, pharmaceutical, diagnostic and biotech industries. Our full contract services include complete product design & development in our TDC Medical organization, tooling design and fabrication, process design and validation, cleanroom injection, insert and two-shot molding, complete device assembly and packaging and sterility validation and management. The MedTech Group, Inc. invests extensive time and effort in learning and examining the healthcare market to better understand our customers' products and their uses.
For additional information on The MedTech Group, Inc., visit our website at or contact Jennifer Bivona at  908-561-0717 ext. 647.


Suggested Articles

Canadian biotech AbCellera has nabbed a meaty $105 million series B funding round as it looks to boost its antibody work and seek out new potential me

Q32 Bio is working on treatments for autoimmune and inflammatory diseases that improve on systemic approaches.

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.